Research

RNA-binding proteins, primary prostate tumours, population-based analyses in diagnostics

Interests

He is one of only a handful of academic surgeons in the UK to be awarded the RCSEng/CR-UK Clinician Scientist Fellowship in Surgery, which supports a laboratory-based research programme at Barts Cancer Institute, Queen Mary University of London. Work in his laboratory focusses on how key genetic changes in prostate cancer cells allow them to become resistant to various treatments and spread to other parts of the body.

Publications

Publications of specific relevance to Applied Data Science

2021

De Laere B, Crippa A, Mortezavi A, Ghysel C, Rajan P, Eklund M, Wyatt A, Dirix L, Ost P, Grönberg H and Lindberg J (2021). Increased pathway complexity is a prognostic biomarker in metastatic castration-resistant prostate cancer. Cancers  vol. 13, (7) 10.3390/cancers13071588

Guo T, Wang Y, Jia J, Mao X, Stankiewicz E, Scandura G, Burke E, Xu L, Marzec J, Davies CR, Lu JJ, Rajan P, Grey A, Tipples K, Hines J, Kudahetti S, Oliver T, Powles T, Alifrangis C, Kohli M, Shaw G, Wang W, Feng N, Shamash J, Berney D, Wang L and Lu YJ (2021). The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing. Frontiers in Cell and Developmental Biology  vol. 8, 10.3389/fcell.2020.602493

2020

Kasivisvanathan V, Lindsay J, Rakshani-Moghadam S, Elhamshary A, Kapriniotis K, Kazantzis G, Syed B, Hines J, Bex A, Ho DH, Hayward M, Bhan C, MacDonald N, Clarke S, Walker D, Bellingan G, Moore J, Rohn J, Muneer A, Roberts L, Haddad F, Kelly JD, Abdel-Aziz TE, Allen C, Allen S, Alnajjar H, Andrich D, Arumuham V, Aslam N and Barod R (2020). A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site. International Journal of Surgery  vol. 84, 57-65. 10.1016/j.ijsu.2020.10.019

Sridhar AN, Sooriakumaran P, Rajan P, Shaw G, Briggs T, Kelly J, Dasgupta P, Desai M, Wiklund P, Haese A, Montorsi F, Ahmad I, Dutto L, Wagner C, Witt J, Adshead J, Patel V and Nathan S (2020). Corrigendum to “A standard operating technique to facilitate early return of urinary continence after robotic prostatectomy outcomes of a consensus meeting of experts with experience of over 30,000 cases” [Eur Urol Suppl 2017;16;e2301–2]. European Urology Open Science  vol. 22, 1-2. 10.1016/j.euros.2020.09.001

Thompson JE, Sridhar AN, Shaw G, Rajan P, Mohammed A, Briggs TP, Nathan S, Kelly JD and Sooriakumaran P (2020). Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation. Bmc Urology  vol. 20, (1) 10.1186/s12894-020-00656-9

Phukan C, Mclean A, Nambiar A, Mukherjee A, Somani B, Krishnamoorthy R, Sridhar A, Rajan P, Sooriakumaran P and Rai BP (2020). Retzius sparing robotic assisted radical prostatectomy vs. conventional robotic assisted radical prostatectomy: a systematic review and meta-analysis. World Journal of Urology  vol. 38, (5) 1123-1134. 10.1007/s00345-019-02798-4

Lauria A, Peirone S, Giudice MD, Priante F, Rajan P, Caselle M, Oliviero S and Cereda M (2020). Identification of altered biological processes in heterogeneous RNA-sequencing data by discretization of expression profiles. Nucleic Acids Research  vol. 48, (4) 1730-1747. 10.1093/nar/gkz1208

Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, Marzec J, Abdu S, Stankiewicz E, Davies CR, Rajan P, Tipples K, Hines J, Chan PY, Campbell D, Wilkinson K, Kudahetti S, Shamash J, Oliver T, Berney D, Shaw G and Lu YJ (2020). Reply by Authors. The Journal of Urology  vol. 203, (1) 81-82. 10.1097/01.JU.0000602796.11621.76

Sehmbi AS, Sridhar AN, Sahadevan K, Rai BP, Nwangwu P, Mohammed A, Freeman A, Mottrie A, Olsson MJ, Wiklund NP, Nathan MS, Briggs TP, Kelly JD and Rajan P (2020). Early outcomes of robot-assisted radical prostatectomy following completion of a structured training curriculum: a single surgeon cohort study. Journal of Clinical Urology  10.1177/2051415820938176

2019

De Laere B, Crippa A, Ghysel C, Ost P, Rajan P, Eklund M, Dirix L, Grönberg H and Lindberg J (2019). 106PElevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer. Annals of Oncology  vol. 30, (Supplement_5) v30-v31. 10.1093/annonc/mdz239.017

Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, Marzec J, Abdu S, Stankiewicz E, Davies CR, Rajan P, Tipples K, Hines J, Chan PY, Campbell D, Wilkinson K, Kudahetti S, Shamash J, Oliver T, Berney D, Shaw G and Lu Y-J (2019). Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells. The Journal of Urology  vol. 203, 101097JU000-101097JU000. 10.1097/JU.0000000000000475

Thompson JE, Sridhar AN, Tan WS, Freeman A, Haider A, Allen C, Moore CM, Orczyk C, Mazzon G, Khetrapal P, Shaw G, Rajan P, Mohammed A, Briggs TP, Nathan S, Kelly JD and Sooriakumaran P (2019). Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound. J Urol  vol. 201, (6) 1134-1143. 10.1097/JU.0000000000000135

De Laere B, Rajan P, Grönberg H, Dirix L, Lindberg J and CORE-ARV-CTC and ProBIO Investigators (2019). Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer. Jama Oncol  10.1001/jamaoncol.2019.0869

Heavey S, Costa H, Pye H, Burt EC, Jenkinson S, Lewis GR, Bosshard-Carter L, Watson F, Jameson C, Ratynska M, Ben-Salha I, Haider A, Johnston EW, Feber A, Shaw G, Sridhar A, Nathan S, Rajan P, Briggs TP, Sooriakumaran P, Kelly JD, Freeman A and Whitaker HC (2019). PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens. Prostate  vol. 79, (7) 768-777. 10.1002/pros.23782

De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert EG, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff IE, van Dam V, Brouwer A, Goossens D, Heyrman L, Van den Eynden GG, Rutten A, Favero JD, Rantalainen M and Rajan P (2019). TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer. Clinical Cancer Research  vol. 25, (6) 1766-1773. 10.1158/1078-0432.CCR-18-1943

2018

Mayrhofer M, De Laere B, Whitington T, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, De Maeseneer D, Strijbos M, Bols A, Fransis K, Oeyen S, Van Dam PJ, Van Den Eynden G, Rutten A, Aly M, Nordström T, Van Laere S, Rantalainen M, Rajan P, Egevad L, Ullén A, Yachnin J and Dirix L (2018). Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis. Genome Medicine  vol. 10, (1) 10.1186/s13073-018-0595-5

Munkley J, Maia TM, Ibarluzea N, Livermore KE, Vodak D, Ehrmann I, James K, Rajan P, Barbosa-Morais NL and Elliott DJ (2018). Androgen-dependent alternative mRNA isoform expression in prostate cancer cells. F1000 Research Ltd  F1000research  vol. 7, 1189-1189. 10.12688/f1000research.15604.1

Foxler DE, Bridge KS, Foster JG, Grevitt P, Curry S, Shah KM, Davidson KM, Nagano A, Gadaleta E, Rhys HI, Kennedy PT, Hermida MA, Chang T-Y, Shaw PE, Reynolds LE, McKay TR, Wang H-W, Ribeiro PS, Plevin MJ, Lagos D, Lemoine NR, Rajan P, Graham TA, Chelala C, Hodivala-Dilke KM, Spendlove I and Sharp TV (2018). A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia. Embo Mol Med  10.15252/emmm.201708304

Rajan P, Hagman A, Sooriakumaran P, Nyberg T, Wallerstedt A, Adding C, Akre O, Carlsson S, Hosseini A, Olsson M, Egevad L, Wiklund F, Steineck G and Wiklund NP (2018). Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up. European Urology Focus  vol. 4, (3) 351-359. 10.1016/j.euf.2016.10.007

Lamb BW and Rajan P (2018). The practicing urologists’ guide to clinical research. Journal of Clinical Urology  10.1177/2051415818761528

2017

Rajan P, Sooriakumaran P, Nyberg T, Akre O, Carlsson S, Egevad L, Steineck G and Wiklund NP (2017). Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study. J Clin Oncol  vol. 35, (31) 3566-3574. 10.1200/JCO.2016.70.7794

Munkley J, Livermore K, Rajan P and Elliott DJ (2017). RNA splicing and splicing regulator changes in prostate cancer pathology. Human Genetics  vol. 136, (9) 1143-1154. 10.1007/s00439-017-1792-9

Sridhar AN, Abozaid M, Rajan P, Sooriakumaran P, Shaw G, Nathan S, Kelly JD and Briggs TP (2017). Surgical Techniques to Optimize Early Urinary Continence Recovery Post Robot Assisted Radical Prostatectomy for Prostate Cancer. Current Urology Reports  vol. 18, (9) 10.1007/s11934-017-0717-4

Munkley J, McClurg UL, Livermore KE, Ehrmann I, Knight B, Mccullagh P, Mcgrath J, Crundwell M, Harries LW, Leung HY, Mills IG, Robson CN, Rajan P and Elliott DJ (2017). The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration. Macmillan Publishers Limited, Part of Springer Nature  Sci Rep  vol. 7, (1) 5249-5249. 10.1038/s41598-017-05489-5

2016

Lamb BW and Rajan P (2016). Clinical Research Toolkit for Urologists. Journal of Clinical Urology  vol. 9, (3) 10.1177/2051415816632390

Munkley J, Vodak D, Livermore KE, James K, Wilson BT, Knight B, Mccullagh P, Mcgrath J, Crundwell M, Harries LW, Leung HY, Robson CN, Mills IG, Rajan P and Elliott DJ (2016). Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability. Elsevier: Creative Commons  Ebiomedicine  10.1016/j.ebiom.2016.04.018

2015

Stockley J, Markert E, Zhou Y, Robson CN, Elliott DJ, Lindberg J, Leung HY and Rajan P (2015). The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7. Scientific Reports  vol. 5, 10.1038/srep13426

Rajan P, Frew JA, Wilson JM, Azzabi AST, McMenemin RM, Stockley J, Soomro NA, Durkan G, Pedley ID and Leung HY (2015). Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer. Urologic Oncology: Seminars and Original Investigations  vol. 33, (8) 337.e1-337.e6. 10.1016/j.urolonc.2015.05.012

Cartwright R, Kirby AC, Tikkinen KAO, Mangera A, Thiagamoorthy G, Rajan P, Pesonen J, Ambrose C, Gonzalez-Maffe J, Bennett P, Palmer T, Walley A, Järvelin MR, Chapple C and Khullar V (2015). Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. American Journal of Obstetrics and Gynecology  vol. 212, (2) 199.e1-199.e24. 10.1016/j.ajog.2014.08.005

Munkley J, Lafferty NP, Kalna G, Robson CN, Leung HY, Rajan P and Elliott DJ (2015). Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells. Bmc Cancer  vol. 15, (1) 10.1186/s12885-015-1012-8

Munkley J, Oltean S, Vodák D, Wilson BT, Livermore KE, Zhou Y, Star E, Floros VI, Johannessen B, Knight B, McCullagh P, McGrath J, Crundwell M, Skotheim RI, Robson CN, Leung HY, Harries LW, Rajan P, Mills IG and Elliott DJ (2015). The androgen receptor controls expression of the cancerassociated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer. Oncotarget  vol. 6, (33) 34358-34374. 10.18632/oncotarget.6024

Munkley J, Livermore KE, McClurg UL, Kalna G, Knight B, McCullagh P, McGrath J, Crundwell M, Leung HY, Robson CN, Harries LW, Rajan P and Elliott DJ (2015). The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells. Oncoscience  vol. 2, (9) 755-764. 10.18632/oncoscience.243

Rajan P and Leung HY (2015). Experimental urological oncology: Cellular, molecular, and animal. Urological Oncology  10.1007/978-0-85729-482-1_2

Anastasiadis E, Rajan P and Winchester CL (2015). Framing a research question: The first and most vital step in planning research. Journal of Clinical Urology  vol. 8, (6) 409-411. 10.1177/2051415815612049

Hendry J, Fraser S, White J, Rajan P and Hendry DS (2015). Retroperitoneal lymph node dissection (RPLND) for malignant phenotype Leydig cell tumours of the testis: a 10-year experience. Springerplus  vol. 4, (1) 10.1186/s40064-014-0781-x

2014

Rajan P, Stockley J, Sudbery IM, Fleming JT, Hedley A, Kalna G, Sims D, Ponting CP, Heger A, Robson CN, McMenemin RM, Pedley ID and Leung HY (2014). Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer. Bmc Cancer  vol. 14, (1) 10.1186/1471-2407-14-977

Stockley J, Villasevil MEM, Nixon C, Ahmad I, Leung HY and Rajan P (2014). The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer. Rna Biology  vol. 11, (6) 10.4161/rna.28800

Zafar N, Miller S, Leburn V, Qureshi KN and Rajan P (2014). Unravelling the prostate-specific antigen controversy: A west of scotland perspective. Scottish Medical Journal  vol. 59, (2) 126-129. 10.1177/0036933014528618

Rajan P, Sudbery IM, Villasevil MEM, Mui E, Fleming J, Davis M, Ahmad I, Edwards J, Sansom OJ, Sims D, Ponting CP, Heger A, McMenemin RM, Pedley ID and Leung HY (2014). Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. European Urology  vol. 66, (1) 32-39. 10.1016/j.eururo.2013.08.011

Munkley J, Rajan P, Lafferty NP, Dalgliesh C, Jackson RM, Robson CN, Leung HY and Elliott DJ (2014). A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation. Oncotarget  vol. 5, (1) 131-139. 10.18632/oncotarget.1405

Cartwright R, Mangera A, Tikkinen KAO, Rajan P, Pesonen J, Kirby AC, Thiagamoorthy G, Ambrose C, Gonzalez-Maffe J, Bennett PR, Palmer T, Walley A, Järvelin MR, Khullar V and Chapple C (2014). Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men. European Urology  vol. 66, (4) 752-768. 10.1016/j.eururo.2014.01.007

Cartwright R, Mariappan P, Turner KJ, Stewart LH and Rajan P (2014). Is there seasonal variation in symptom severity, uroflowmetry and frequency–volume chart parameters in men with lower urinary tract symptoms? Scottish Medical Journal  vol. 59, (3) 162-166. 10.1177/0036933014542393

2013

Barry L, Baxter G, Pitchamuthu H, Crooks JE, Rajan P and Ahmad I (2013). Aggressive bladder leiomyosarcoma in a patient receiving tamoxifen therapy. Journal of Clinical Urology  vol. 6, (5) 327-329. 10.1177/2051415813486467

2012

Barry L, Ahmad I, Pokrovska T and Rajan P (2012). Current management options for the small renal mass in a solitary kidney. Scottish Medical Journal  vol. 57, (3) 157-162. 10.1258/smj.2012.012022

2011

Rajan P, Dalgliesh C, Carling PJ, Buist T, Zhang C, Grellscheid SN, Armstrong K, Stockley J, Simillion C, Gaughan L, Kalna G, Zhang MQ, Robson CN, Leung HY and Elliott DJ (2011). Identification of novel androgen-regulated pathways and mrna isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome. Plos One  vol. 6, (12) 10.1371/journal.pone.0029088

Magill LJ, Rajan P, Zafar N, Seywright M and Hendry DS (2011). Endocervicosis and endosalpingiosis of the urinary bladder: A case report. British Journal of Medical and Surgical Urology  vol. 4, (3) 128-130. 10.1016/j.bjmsu.2010.05.001

Rajan P, Menon A and Crofts TJ (2011). Teaching corner-lumps and bumps: A practical guide to minor surgery for the Core Surgical Trainee. Malawi Medical Journal  vol. 23, (2) 54-57. 10.4314/mmj.v23i2.70748

2010

Rajan P, Turner KJ, Mariappan P and Stewart LH (2010). A one-day frequency-volume chart is representative of a 3-day chart in the assessment of lower urinary tract symptoms suggestive of bladder outflow obstruction. British Journal of Medical and Surgical Urology  vol. 3, (5) 194-197. 10.1016/j.bjmsu.2010.01.009

Elliott DJ and Rajan P (2010). The role of the RNA-binding protein Sam68 in mammary tumourigenesis. Journal of Pathology  vol. 222, (3) 223-226. 10.1002/path.2753

2009

Rajan P and Rajan VV (2009). Giving evidence in the Scottish Criminal Courts: A guide for junior doctors. Internet Journal of Law, Healthcare and Ethics  vol. 6, (1)

Rajan P, Dalgliesh C, Bourgeois CF, Heiner M, Emami K, Clark EL, Bindereif A, Stevenin J, Robson CN, Leung HY and Elliott DJ (2009). Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 nuclear bodies. Bmc Cell Biology  vol. 10, 10.1186/1471-2121-10-82

Rajan P and Turna B (2009). New trends in minimally invasive urological surgery. International Braz J Urol  vol. 35, (5) 514-520. 10.1590/S1677-55382009000500002

Rajan P, Elliott DJ, Robson CN and Leung HY (2009). Alternative splicing and biological heterogeneity in prostate cancer. Nature Reviews Urology  vol. 6, (8) 454-460. 10.1038/nrurol.2009.125

Rajan P, Raza A, Pemberton RJ and Tolley DA (2009). Testicular torsion following a skin graft for Fournier's gangrene. International Journal of Clinical Practice  vol. 63, (1) 176-177. 10.1111/j.1742-1241.2005.00717.x

Carling PJ, Elliott DJ, Robson CN, Leung HY and Rajan P (2009). Targeting alternative splicing in prostate oncology. Discovery Medicine  vol. 8, (41) 74-80.

2008

Rajan P and Leung HY (2008). Animal models in genitourinary malignancies. Urological Oncology  10.1007/978-1-84628-738-1_2

Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S, Heer R, Gaughan L, Leung HY, Elliott DJ, Fuller-Pace FV and Robson CN (2008). The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Research  vol. 68, (19) 7938-7946. 10.1158/0008-5472.CAN-08-0932

Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, Leung HY and Elliott DJ (2008). Regulation of gene expression by the RNA-binding protein Sam68 in cancer. Biochemical Society Transactions  vol. 36, (3) 505-507. 10.1042/BST0360505

Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, Leung HY and Elliott DJ (2008). The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor. Journal of Pathology  vol. 215, (1) 67-77. 10.1002/path.2324

2007

Mariappan P, Turner KJ, Sothilingam S, Rajan P, Sundram M and Stewart LH (2007). Nocturia, nocturia indices and variables from frequency-volume charts are significantly different in Asian and Caucasian men with lower urinary tract symptoms: A prospective comparison study. Bju International  vol. 100, (2) 332-336. 10.1111/j.1464-410X.2007.06979.x

2006

Rajan P, McNeill SA and Turner KJ (2006). Is frenuloplasty worthwhile? A 12-year experience. Annals of The Royal College of Surgeons of England  vol. 88, (6) 583-584. 10.1308/003588406X130633

Menon A and Rajan P (2006). The irreversible decline in anatomical confidence amongst surgical trainees: Fact or fiction [1]. Clinical Anatomy  vol. 19, (2) 180-181. 10.1002/ca.20295

2005

Rajan P, Menon A and Durani P (2005). Research during surgical training: Why are we doing it? [1]. British Journal of Hospital Medicine  vol. 66, (8)

Rice SA, Rajan P, Hansen R and Munro FD (2005). Painful attraction: A magnetic penile injury. Journal of The Royal Society of Medicine  vol. 98, (3) 122-123. 10.1258/jrsm.98.3.122

Rajan P and Tolley DA (2005). Does slower delivery of shock-wave lithotripsy improve treatment efficacy for urolithiasis? Nature Clinical Practice Urology  vol. 2, (3) 132-133. 10.1038/ncpuro0118

Rajan P and Tolley DA (2005). Artificial neural networks in urolithiasis. Current Opinion in Urology  vol. 15, (2) 133-137. 10.1097/01.mou.0000160629.81978.7a

Wilkinson AG, Rajan P and MacKinlay GA (2005). Endoluminal balloon dilatation for pelvi-ureteric junction obstruction in children: An effective alternative to open pyeloplasty. Journal of Pediatric Urology  vol. 1, (4) 301-305. 10.1016/j.jpurol.2005.01.013

Rajan P and Din NA (2005). Sub-specialization in general surgery - The end of the 'general' surgeon? Hospital Medicine  vol. 66, (3) 10.12968/hmed.2005.66.3.17694

Grants

Grants of specific relevance to Applied Data Science

Sam68 and hnRNPA2 in prostate cancer
Rajan P
£800,000 Cancer Research UK (01-05-2013 - 30-01-2020)

Summary